Dear friends and colleagues,
I would like to personally invite you to meet Dr. Joanne Kurtzberg on October 15th during a special LIVE edition of Share the Science at AABB 2018. Save the Cord Foundation is honored to be collaborating with WellSky Health (formerly known as Mediware, Inc.) on this prestigious event. Equally, we are thrilled to welcome Dr. Kurtzberg as our featured speaker.
REGISTER HERE: Share the Science LIVE at AABB 2018 with Dr. Joanne Kurtzberg http://cts.vresp.com/c/?SavetheCordFoundatio/8df8d3e9c0/fa44a1cc92/162a7cc264/utm_content=Hanson&utm_source=VerticalResponse&utm_medium=Email&utm_term=REGISTER HERE: Share the Science LIVE at AABB 2018 with Dr. Joanne Kurtzberg&utm_campaign=You're invited to meet Dr. Joanne Kurtzberg
Boston Convention Center in room 151 AB | October 15th from 7:00 - 8:15 a.m. ET
As always, this event is free and open to all; however, registration is required and places are limited.
Have we crossed into new territory with cord blood?
This year the world celebrates 30 years since the first cord blood transplant was performed. Dr. Joanne Kurtzberg was there. Indeed, Matthew Farrow was her patient. Working together with an international team led by Dr. Eliane Gluckman, the hope was that a cord blood transplant from Matthew's sister would cure him of fanconi anemia. The procedure worked and this milestone procedure opened the door to a multitude of potential uses for cord blood.
Today, cord blood is routinely used to treat more than 80 different life-threatening diseases including many blood cancers. We are also seeing exciting research in the use of cord blood stem cells for regenerative medicine. In particular, researchers are beginning to manipulate cord blood and develop cord blood derived therapies.
Dr. Kurtzberg is one of the best known researchers in this field working primarily with children suffering from various brain injuries. Her studies in children with selective inborn errors of metabolism have shown that cord blood cells, administered intravenously after myeloablative therapy engraft in the brain. DUOC-01, a cord blood derived cellular therapy that promotes myelination, is undergoing testing to augment standard umbilical cord blood treatment in children with leukodystrophies. We look forward to hearing Dr. Kurtzberg explain how these observations have led us to hypothesize that cord blood cells might also have efficacy treating patients with acquired brain injuries and potential uses of allogeneic cord blood. Learn more about Dr. Joanne Kurtzberg here.
Extending Cord Blood to Regenerative Therapies for the Brain
Boston Convention Center in room 151 AB | October 15th from 7:00 - 8:15 a.m. ET
Brought to you by Save the Cord Foundation and WellSky Health
Event is RSVP only. Admission is free but seating is limited.
REGISTER HERE: https://tinyurl.com/ShareTheScienceLive
Please register early to guarantee your space.
We look forward to having you join us!
Charis Ober
Executive Director
Save the Cord Foundation
www.SaveTheCordFoundation.org
I would like to personally invite you to meet Dr. Joanne Kurtzberg on October 15th during a special LIVE edition of Share the Science at AABB 2018. Save the Cord Foundation is honored to be collaborating with WellSky Health (formerly known as Mediware, Inc.) on this prestigious event. Equally, we are thrilled to welcome Dr. Kurtzberg as our featured speaker.
REGISTER HERE: Share the Science LIVE at AABB 2018 with Dr. Joanne Kurtzberg http://cts.vresp.com/c/?SavetheCordFoundatio/8df8d3e9c0/fa44a1cc92/162a7cc264/utm_content=Hanson&utm_source=VerticalResponse&utm_medium=Email&utm_term=REGISTER HERE: Share the Science LIVE at AABB 2018 with Dr. Joanne Kurtzberg&utm_campaign=You're invited to meet Dr. Joanne Kurtzberg
Boston Convention Center in room 151 AB | October 15th from 7:00 - 8:15 a.m. ET
As always, this event is free and open to all; however, registration is required and places are limited.
Have we crossed into new territory with cord blood?
This year the world celebrates 30 years since the first cord blood transplant was performed. Dr. Joanne Kurtzberg was there. Indeed, Matthew Farrow was her patient. Working together with an international team led by Dr. Eliane Gluckman, the hope was that a cord blood transplant from Matthew's sister would cure him of fanconi anemia. The procedure worked and this milestone procedure opened the door to a multitude of potential uses for cord blood.
Today, cord blood is routinely used to treat more than 80 different life-threatening diseases including many blood cancers. We are also seeing exciting research in the use of cord blood stem cells for regenerative medicine. In particular, researchers are beginning to manipulate cord blood and develop cord blood derived therapies.
Dr. Kurtzberg is one of the best known researchers in this field working primarily with children suffering from various brain injuries. Her studies in children with selective inborn errors of metabolism have shown that cord blood cells, administered intravenously after myeloablative therapy engraft in the brain. DUOC-01, a cord blood derived cellular therapy that promotes myelination, is undergoing testing to augment standard umbilical cord blood treatment in children with leukodystrophies. We look forward to hearing Dr. Kurtzberg explain how these observations have led us to hypothesize that cord blood cells might also have efficacy treating patients with acquired brain injuries and potential uses of allogeneic cord blood. Learn more about Dr. Joanne Kurtzberg here.
Extending Cord Blood to Regenerative Therapies for the Brain
Boston Convention Center in room 151 AB | October 15th from 7:00 - 8:15 a.m. ET
Brought to you by Save the Cord Foundation and WellSky Health
Event is RSVP only. Admission is free but seating is limited.
REGISTER HERE: https://tinyurl.com/ShareTheScienceLive
Please register early to guarantee your space.
We look forward to having you join us!
Charis Ober
Executive Director
Save the Cord Foundation
www.SaveTheCordFoundation.org